Form 4: Fuller H. Co. Executive Reports Stock Transactions
Statement of Changes in Beneficial Ownership
John J. Corkrean, Executive VP and CFO of Fuller H. Co., reported transactions involving common stock, phantom units, and stock options.
Summary
- John J. Corkrean, Executive Vice President and Chief Financial Officer of Fuller H. Co. (FUL), has filed a Form 4 detailing changes in his beneficial ownership of company securities.
- The filing indicates transactions related to common stock, phantom units, and various employee stock options.
- Corkrean directly holds 59,508 shares of common stock.
- He also holds a significant number of vested and unvested stock options with exercise prices ranging from $45.05 to $77.72.
- Additionally, the report details holdings in phantom units and restricted stock units, some of which include dividend equivalents and have vesting schedules.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine insider transactions and does not indicate significant buying or selling pressure that would strongly influence sentiment.
Positives
- The reporting person, John J. Corkrean, holds a substantial direct ownership of 59,508 shares of common stock.
- A significant number of stock options are vested, indicating potential for future gains if the stock price appreciates.
- The company utilizes various equity-based compensation instruments like phantom units and restricted stock units, which can align executive interests with shareholders.
Negatives
- The filing does not provide specific details on the sale or acquisition prices of securities, only the acquisition of phantom units.
- Several stock options are unvested, meaning their value is contingent on future performance and continued employment.
- The complexity of the equity holdings, including phantom units and restricted stock units with dividend equivalents, can make valuation and understanding difficult for some investors.
Risks
- The value of unvested stock options is subject to market fluctuations and the company's future performance.
- Changes in executive compensation structures or equity awards could signal internal strategic shifts or challenges.
- The reliance on stock options and other equity awards for executive compensation carries inherent risks tied to stock price volatility.
Future Outlook
The filing does not contain forward-looking statements or guidance. It primarily reports on past transactions and current beneficial ownership.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and are crucial for understanding executive confidence and potential shifts in beneficial ownership within the industrial manufacturing sector.
Stakeholder Impact
- Shareholders: The filing provides transparency into executive holdings, which can inform investment decisions. The vested stock options represent potential future dilution if exercised.
- Employees: The continued use of stock options and restricted stock units suggests a compensation strategy aimed at retaining and motivating key personnel.
- Management: The filing reflects the ongoing equity compensation and ownership of a key executive, aligning with typical corporate governance practices.
Key Dates
| Date | Description |
|---|---|
| 01/24/2019 | Vesting start date for Employee Stock Option with exercise price $53.57. |
| 01/26/2018 | Vesting start date for Employee Stock Option with exercise price $50.10. |
| 01/26/2025 | Vesting start date for Restricted Stock Units. |
| 01/26/2027 | Vesting start date for Employee Stock Option with exercise price $59.81. |
| 01/26/2029 | Vesting end date for Restricted Stock Units. |
| 01/26/2036 | Expiration date for Employee Stock Option with exercise price $59.81. |
| 01/27/2026 | Vesting start date for Restricted Stock Units. |
| 01/27/2028 | Vesting end date for Restricted Stock Units. |
| 01/27/2031 | Expiration date for Employee Stock Option with exercise price $51.89. |
| 01/27/2035 | Expiration date for Employee Stock Option with exercise price $64.28. |
| 01/24/2020 | Vesting start date for Employee Stock Option with exercise price $45.05. |
| 01/24/2023 | Vesting start date for Employee Stock Option with exercise price $72.94. |
| 01/24/2024 | Vesting start date for Employee Stock Option with exercise price $68.17. |
| 01/24/2029 | Expiration date for Employee Stock Option with exercise price $45.05. |
| 01/24/2032 | Expiration date for Employee Stock Option with exercise price $72.94. |
| 01/24/2033 | Expiration date for Employee Stock Option with exercise price $68.17. |
| 01/24/2030 | Expiration date for Employee Stock Option with exercise price $48.35. |
| 01/26/2027 | Vesting start date for Employee Stock Option with exercise price $59.81. |
| 01/26/2034 | Expiration date for Employee Stock Option with exercise price $77.72. |
| 01/27/2026 | Vesting start date for Employee Stock Option with exercise price $64.28. |
| 01/27/2030 | Expiration date for Employee Stock Option with exercise price $50.10. |
| 05/08/2026 | Earliest transaction date reported and acquisition date for Phantom Units. |
| 05/11/2026 | Date of filing. |
Keywords
Form 4, SEC Filing, Beneficial Ownership, Stock Transactions, Executive Compensation, Fuller H. Co., FUL, Stock Options, Phantom Units, Restricted Stock Units, John J. Corkrean, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.